跳至主要内容
临床试验/NCT02047448
NCT02047448已完成2 期

Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model

Wilkes University2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
180
试验地点
2
主要终点
Medication Adherence

研究概览

简要总结

The purpose of this pilot study is to determine if medication adherence is improved by a transitional care pharmacy practice model designed to integrate hospital and community pharmacists in the care and education of patients with heart failure or COPD who are discharged from a community hospital to home. The hospital and community pharmacists will collaborate with each other, the patient, and other practitioners including the primary care physician, nurse, and case manager to prevent and correct medication-related problems and attempt to improve patient outcomes especially during the error-prone transition from hospital to home.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • admitted to hospital with a primary or secondary diagnosis of heart failure or COPD
  • anticipated eventual discharge to home
  • agreeable to participate in monthly counseling sessions (if randomized to intervention group) from a participating community pharmacist

排除标准

  • presence of cognitive impairment or dementia that would significantly prevent effective patient education and counseling
  • non English-speaking
  • anticipated discharge to a long-term care or skilled nursing facility on a permanent basis
  • permanent long-term care facility residents
  • surgical patients
  • hospice patients
  • patients who die within 30 days of initial study hospitalization

结局指标

主要结局

Medication Adherence

时间窗: 6 months

The primary endpoint will be medication adherence as measured by the Proportion of Days Covered (PDC) calculation. This is calculated by dividing the total days' supply dispensed by 180 days. Medications considered in this calculation will include those used for the treatment of heart failure or COPD and known to improve outcomes. The composite PDC will be an average of the individual PDC for each drug class.

次要结局

  • Patient Satisfaction(6 months)
  • Hospital readmissions or ED visits(6 months)
  • Medication related problems(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Judith L. Kristeller

Associate Professor

Wilkes University

研究点 (2)

Loading locations...

相似试验